REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Rovifarma Vaistine (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: UAB Rovifarma Vaistine Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Rovifarma Vaistine is a Lithuanian pharmacy retail company based in Klaipeda, engaged in the retail sale of pharmaceutical products, medical supplies, hygiene items, cosmetics, vitamins and related health-oriented goods through its licensed pharmacy outlet. The company's business operations encompass dispensing prescription and over-the-counter medications, providing consumer health products and medical consumables, and serving general public pharmaceutical needs in its local catchment area, supported by professional pharmacy staff and compliance with regulated retail pharmacy standards. With recorded annual sales revenue and net profit figures indicating a stable commercial performance, UAB Rovifarma Vaistine focuses on delivering accessible pharmacy services, maintaining product quality and availability, and meeting the healthcare needs of its customer base within the Klaipeda region.

Headquarters
Liepojos g. 49
Klaipeda; Klaipeda County; Postal Code: LT-92288

Contact Details: Purchase the UAB Rovifarma Vaistine report to view the information.

Basic Information
Total Employees:
Purchase the UAB Rovifarma Vaistine report to view the information.
Registered Capital:
Purchase the UAB Rovifarma Vaistine report to view the information.
Financial Auditors:
Purchase the UAB Rovifarma Vaistine report to view the information.
Incorporation Date:
September 21, 1998
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Rovifarma Vaistine report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
17.57%
Total operating revenue
17.57%
Net Profit/Loss for the Period
-19.78%
Total Equity
24.62%
Net Profit Margin
-0.36%
Return on Equity (ROE)
-10.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?